Skip to content

Coxa Magna following treatment for developmental dislocation of the hip: Investigation of associated risk factors.

Coxa Magna following treatment for developmental dislocation of the hip: Investigation of associated risk factors.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056044
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-12
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Developmental Dysplasia of Hip

Interventions

Group 1:closed reduction and/or closed reduction with extraarticular tenatomy
Group 2:Open reduction (medial or anterior) and/or open reduction with acetebular osteotomy

Sponsors

None
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with typical DDH radiologically and clinically, had healthy archival records, and were followed up regularly for at least four years were included in the study. In general, regular records of 143 patients were accessed. Of these, 119 patients had at least four years of regular follow-up.

Exclusion criteria

Exclusion criteria: Cases who underwent revision surgery were excluded in order to minimize the factors that would affect the results of the study. 15 patients.

Design outcomes

Primary

MeasureTime frame
Frequency of Coxa Magna and Avascular necrosis;

Secondary

MeasureTime frame
Risk factors associated with CM;

Countries

Turkey

Contacts

Public ContactAhmet Aslan

Alanya Alaaddin Keykubat University

draaslan@hotmail.com+90 50 56462411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026